01 3MERCK SHARP DOHME
02 5MSD MERCK CO
03 13VIIV HLTHCARE
01 17754731
02 38129385
03 38486975
04 39242986
05 110603282
06 110842751
07 111234985
08 17169780*PED
09 17754731*PED
10 38129385*PED
11 39242986*PED
01 10Y
02 11Blank
01 13Y
02 8Blank
01 12024-04-03
02 32027-10-05
03 32028-04-05
04 12029-03-11
05 12029-09-11
06 32029-12-08
07 32030-06-08
08 12031-01-24
09 32031-10-07
10 22036-11-29
Patent Expiration Date : 2029-03-11
LAMIVUDINE; RALTEGRAVIR POTASSIUM
US Patent Number : 7754731
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 206510
Patent Use Code : U-1663
Delist Requested :
Patent Use Description : TREATMENT OF HIV-1 INF...
Patent Expiration Date : 2029-03-11
Patent Expiration Date : 2029-09-11
LAMIVUDINE; RALTEGRAVIR POTASSIUM
US Patent Number : 7754731*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 206510
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-09-11
Patent Expiration Date : 2024-04-03
LAMIVUDINE; RALTEGRAVIR POTASSIUM
US Patent Number : 7169780*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 206510
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-04-03
Patent Expiration Date : 2031-10-07
DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8486975
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210807
Patent Use Code : U-2629
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-10-07
Patent Expiration Date : 2031-10-07
DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8486975
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210807
Patent Use Code : U-2395
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-10-07
Patent Expiration Date : 2031-10-07
DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8486975
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210807
Patent Use Code : U-3307
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-10-07
Patent Expiration Date : 2036-11-29
DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 10603282
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210807
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-11-29
Patent Expiration Date : 2036-11-29
DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 10842751
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210807
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-11-29
Patent Expiration Date : 2031-01-24
DOLUTEGRAVIR SODIUM; LAMIVUDINE
US Patent Number : 11234985
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 211994
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2031-01-24
Patent Expiration Date : 2029-12-08
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205551
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
LOOKING FOR A SUPPLIER?
